Drug Shortage Report for JAMP-NYSTATIN ORAL SUSPENSION USP

Last updated on 2025-01-23 History
Report ID 211795
Drug Identification Number 02433443
Brand name JAMP-NYSTATIN ORAL SUSPENSION USP
Common or Proper name Nystatin Oral Suspension USP
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) NYSTATIN
Strength(s) 100000UNIT
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100
ATC code A07AA
ATC description INTESTINALANTIINFECTIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-11-27
Estimated end date 2025-05-31
Actual end date
Shortage status Actual shortage
Updated date 2025-01-23
Company comments Under allocation
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2025-01-23 French Compare
v21 2025-01-23 English Compare
v20 2025-01-04 French Compare
v19 2025-01-04 English Compare
v18 2024-12-03 French Compare
v17 2024-12-03 English Compare
v16 2024-11-01 French Compare
v15 2024-11-01 English Compare
v14 2024-11-01 French Compare
v13 2024-11-01 English Compare
v12 2024-09-04 French Compare
v11 2024-09-04 English Compare
v10 2024-07-03 French Compare
v9 2024-07-03 English Compare
v8 2024-03-11 French Compare
v7 2024-03-11 English Compare
v6 2024-03-04 French Compare
v5 2024-03-04 English Compare
v4 2024-02-19 French Compare
v3 2024-02-19 English Compare

Showing 1 to 20 of 22